CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Microbiota-derived genotoxin tilimycin generates colonic stem cell mutations.
Microbiota-derived genotoxin tilimycin generates colonic stem cell mutations.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
DNA烷化代谢物tilimycin是一种微生物基因毒素。携带til基因的克雷伯菌属细菌(til⁺ Klebsiella)可导致tilimycin在宿主肠道中积聚,引起上皮细胞凋亡性剥脱和结肠炎。肠道内壁更新及损伤应答依赖位于肠隐窝底部的干细胞。本研究探究tilimycin诱导的DNA损伤对增殖中干细胞的影响。我们在复杂微生物群背景下,绘制了克雷伯菌定植小鼠体内til代谢物的空间分布和肠腔浓度。标志基因G6pd功能丧失提示结直肠干细胞发生遗传异常,并在单克隆突变隐窝中稳定存在。与携带非产毒突变菌株的小鼠相比,定植产tilimycin克雷伯菌的小鼠体细胞突变频率更高,且每只受影响个体中的突变数量也更多。我们的发现提示,具有基因毒性的til⁺克雷伯菌可能驱动人类宿主结肠体细胞遗传改变,并增加疾病易感性。
The DNA-alkylating metabolite tilimycin is a microbial genotoxin. Intestinal accumulation of tilimycin in individuals carrying til+ Klebsiella spp. causes apoptotic erosion of the epithelium and colitis. Renewal of the intestinal lining and response to injury requires the activities of stem cells located at the base of intestinal crypts.
This study interrogates the consequences of tilimycin-induced DNA damage to cycling stem cells.
We charted the spatial distribution and luminal quantities of til metabolites in Klebsiella-colonized mice in the context of a complex microbial community. Loss of marker gene G6pd function indicates genetic aberrations in colorectal stem cells that became stabilized in monoclonal mutant crypts. Mice colonized with tilimycin-producing Klebsiella displayed both higher frequencies of somatic mutation and more mutations per affected individual than animals carrying a non-producing mutant.
Our findings imply that genotoxic til+ Klebsiella may drive somatic genetic change in the colon and increase disease susceptibility in human hosts.
MEMBER ACCOUNT
登录成功会直接打开下一页。